Project: A Clinical Candidate for the Treatment of Rheumatoid Arthritis

This project aims to advance a first-in-class drug candidate into clinical phase for the treatment of rheumatoid arthritis (RA) and thereby improve quality of life for these patients. Through the Eurostars project we aim to improve our compounds and demonstrate that our candidates are non-toxic by using pre-clinical, in vivo and in vitro toxicity screening. To collect early clinical data a microdialysis platform will be set up for detection of biomarkers and proof-of-principle studies.

Acronym	CLARA (Reference Number: 10611)
Duration	01/10/2016 - 01/10/2019
Project Topic	Biological Sciences / Technologies
Network	Eurostars 2
Call	Eurostars Cut-Off 5

Project partner

Number	Name	Role	Country
24661	Smerud Medical Research Oy	Partner	Finland
24662	Clinical Trial Consultants AB	Partner	Sweden
24663	Rheumatech AS	Coordinator	Norway